Radiolabeling of epidermal growth factor with 99mTc and in vivo localization following intracerebral injection into normal and glioma-bearing rats

Bioconjugate Chemistry

Volumn 8, Issue 3, 1997, Pages 289-295

  Capala, Jacek ^a,e   Barth, Rolf F ^a   Bailey, Michael Q ^a,b   Fenstermaker, Robert A ^c   Marek, Michael J ^d   Rhodes, Buck A ^d  

^a OHIO STATE UNIVERSITY   (United States)

^b Midwest Vet Diagn Imaging Inc ^*  (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d RhoMed Inc   (United States)

^e BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; GENE EXPRESSION; MONOCLONAL ANTIBODIES; RADIATION; RADIOACTIVITY; RATS;

EPIDERMAL GROWTH FACTOR RECEPTORS; EPIDERMAL GROWTH FACTORS; GLIOMA CELLS; HIGH-GRADE GLIOMAS; IN-VIVO; LOCALISATION; RADIOLABELLING; RADIOLIGANDS; RECEPTOR GENES; TRANSMEMBRANES;

TUMORS;

EID: 0031149232     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc970031s     Document Type: Article

References (51)

1. 131I Conjugates on the Clonogenic Survival of Cultured Glioma Cells. J. Neuro-Oncol. 14, 213-223.
2. Barth, R. F., Soloway, A. H., and Brugger, R. M. (1996) Boron Neutron Capture Therapy of Brain Tumors: Past History, Current Status, and Future Potential. Cancer Invest. 14, 534-550.
3. Barth, R. F., Yang, W., Rotaru, J. H., Moeschberger, M. L., Joel, D. D., Nawrocky, M. M., Goodman, J. H., and Soloway, A. H. (1997) Boron Neutron Capture Therapy of Brain Tumors: Enhanced Survival Following Itracarotid Injection of either Sodium Borocaptate or Borophenylalanine with or without Blood-Brain Barrier Disruption. Cancer Res. 57, 1129-1136.
4. Bigner, S. H., Humphrey, P. A., Wong, A. J., Vogelstein, B., Mark, J., Friedman, H. S., and Bigner, D. D. (1990) Characterization of the Epidermal Growth Factor Receptor in Human Glioma Cell Lines and Xenografts. Cancer Res. 50, 8017-8022.
5. Brady L. W., Miyamoto, C., Woo, D., Rachover, M., Emrich, J., Bender, H., Dadparvar, S., Steplewski, Z., Koprowski, H., Black, P., Lazzaro, B., Nair, S., McCormack, T., Nieves, J., Morabito, M., and Eshleman, J. (1991) Malignant Astrocytomas Treated with Iodine-125 Labelled Monoclonal Antibody 425 Against Epidermal Growth Factor Receptors: A Phase II Trial. Int. J. Radiat. Oncol. Biol. Phys. 22, 225-230.
6. Brem, H., Mahaley, Jr., M. S., Vick, N. A., Black, K. L., Schold, Jr., S. C., Burger, P. C., Friedman, A. H., Ciric, I. S., Eller, T. W., Cozzenes, J. W., and Kenealy, J. N. (1991) Interstitial Chemotherapy with Drug Polymer Implants for the Treatment of Recurrent Gliomas. J. Neurosurg. 74, 441-446.
7. Brightman, M. W. (1989) The Anatomic Basis of the Blood-Brain Barrier. Implications of the Blood-Brain Barrier and Its Manipulation (E. A. Neuwelt, Ed.) Vol. 1, pp 53-83, Plenum Publishing, New York.
8. 131I-EGF. Studies on Cultured Glioma Cells. Int. J. Radiat. Biol. 60, 497-510.
9. 131I-EGF on Cultured Human Glioma Cells. J. Neuro-Oncol. 9, 201-210.
10. 10B to Malignant Gliomas. Advances of Neutron Capture Therapy (A. H. Soloway, R. F. Barth, and D. E. Carpenter, Eds.) pp 371-375, Plenum Press, New York.
11. Capala, J., Barth, R. F., Bendayan, M., Lauzon, M., Adams, D. M., Soloway, A. H., Fenstermaker, R. A., and Carlsson J. (1996) Boronated Epidermal Growth Factor as a Potential Targeting Agent for Boron Neutron Capture Therapy of Brain Tumors. Bioconjugate Chem. 7, 7-15.
12. Carlsson, J., Gedda, L., Grönvik, C., Hartman, T., Lindström, A., Lindström, P., Lundqvist, H., Lövqvist, A., Malmqvist, J., Olsson, P., Essand, M., Pontèn, J., Sjöberg, S., and Westermark, B. (1994) Strategy for Boron Neutron Capture Therapy Against Tumor Cells with Over-Expression of the Epidermal Growth Factor-Receptor. Int. J. Radiat. Oncol. Biol. Phys. 30, 105-115.
13. Carpenter, G. (1987) Receptors for Epidermal Growth Factor and Other Polypeptide Mitogens. Annu. Rev. Biochem. 56, 881-914.
14. 125I-Labeled Epidermal Growth Factor. Binding, Internalization, and Degradation in Human Fibroblasts. J. Cell Biol. 71, 159-171.
15. Carpenter, G., and Cohen, S. (1979) Epidermal Growth Factor. Annu. Rev. Biochem. 48, 193-216.
16. Carrasquillo, J. (1993) Imaging and dosimetry determinations using radiolabeled antibodies. Cancer Treat. Res. 68, 65-97.
17. Clendenon, N. R., Barth, R. F., Gordon, W. A., Goodman, J. H., Alam, F., Staubus, A. E., Boesel, C. P., Yates, A. J., Moeschberger, M. L., Fairchild, R. G., and Kalef-Ezra, J. A. (1990) Boron Neutron Capture Therapy of a Rat Glioma. Neurosurgery 26, 47-55.
18. Ekstrand, A. J., James, C. D., Cavenee, W. K., Selinger, B., Petterson, R. E., and Collins, V. P. (1991) Genes for Epidermal Growth Factor Receptor, Transforming Growth Factor α, and Epidermal Growth Factor and Their Expression in Human Gliomas in Vivo. Cancer Res. 51, 521-527.
19. Epenetos, A. A., Courtney-Luck N., Pickering, D., Hooker, G., Durbin, H., Lavender, J. P., and McKenzie, C. G. (1985) Antibody Guided Irradiation of Brain Glioma by Arterial Infusion of Radioactive Monoclonal Antibody against Epidermal Growth Factor Receptor and Blood Group A Antigen. Br. Med. J. 290, 1463-1466.
20. Faillot, T., Magdelénat, H., Mady, E., Stasiecki, P., Fohanno, D., Gropp, P., Poisson, M., and Delattre, J.-Y. (1996) A Phase I Study of Anti-epidermal Growth Factor Receptor Monoclonal Antibody for the Treatment of Malignant Gliomas. Nurosurgery 39, 478-483.
21. Fenstermaker, R. A., Capala, J., Barth, R. F., Hujer, A., Kung, H.-J., and Kaetzer, Jr., D. M. (1995) The Effect of Epidermal Growth Factor Receptors (EGFR) Expression on in Vivo Growth of Rat C6 Glioma Cells. Leukemia 9 (Suppl. 1 ), S106-S112.
22. Griffiths, G. L., Goldenberg, D. M., Diril, H., and Hansen, H. J. (1994) Technetium-99m, Rhenium-186, and Rhenium-188 Direct-Labeled Antibodies. Cancer 73. 761-768.
23. Harris, A. L. (1990) The Epidermal Growth Factor Receptor as a Target for Therapy. Cancer Cells 2, 321-323.
24. Helseth, E., Brogger, A., Dalen, A., Fure, H., Johansen, S. G., Lier, M. E., Skandsen, T., Unsrard, G., and Vik, R. (1990) Polysomy of Chromosome 7 is Associated with Amplification and Overexpression of the EGF-Receptor Gene in a Human Carcinoma Cell Line Delivered from a Brain Metastasis. Acta Pathol., Microbiol. Immunol. Scand. 98, 996-1004.
25. Kalofonos, H. P., Pawlikowska, T. R., Hemingway, A., Courtenay-Luck, N., Dhokia, B., Snook, D., Sivolapenko, G. B., Hooker, G. R., McKenzie, C. G., Lavender, P. J., Thomas, D. G. T., and Epenetos, A. A. (1989) Antibody Guided Diagnosis and Therapy of Brain Gliomas Using Radiolabeled Monoclonal Antibodies Against Epidermal Growth Factor Receptor and Placental Alkaline Phosphatase. J. Nucl. Med. 30, 1636-1645.
26. Kroin, J. F., and Penn, R. D. (1989) Implantable Pumps to Deliver Drugs Directly into CNS. Implications of The Blood Brain Barrier and Its Manipulation (E. A. Neuwelt, Ed.) Vol. 2, pp 601-615, Plenum Medical Book, New York.
27. Liebert, M., Wahl, R. L., Lawless, G., McKeever, P. E., Taren, J. A., Beierwalters, W. H., and Brasswell, R. (1990) Direct Stereotactic Intracerebral Injection of Monoclonal Antibodies and Their Fragments: A Potential Approach to Brain Tumor Immunotherapy. Am. J. Physiol. Imaging 5, 55-59.
28. Lofts, F. J., and Gullick, W. J. (1994) Growth Factor Receptors as Targets. New Molecular Targets for Cancer Chemotherapy (D. J. Kerr and P. Workman, Eds.) pp 45-66, CRC Press, Boca Raton.
29. Madrit, Y., Feigenbaum Langer, L., Brem, H., and Langer, R. (1991) New Directions for the Delivery of Drugs and Other Substances to the Central Nervous System. Semin. Pharmacol. 22, 299-324.
30. Mendelsohn, J. (1988) Growth Factor Receptors as Targets for Antitumor Therapy with Monoclonal Antibodies. Prog. Allergy 45, 147-160.
31. Modjtahedi, H., and Dean, C. (1991) The Receptor for EGF and Its Ligands: Expression, Prognostic Value and Target for Therapy in Cancer (Review). Int. J. Oncol. 4, 227-296.
32. Neuwelt, E. A, Howieson, J., Frenkel, E. P., Specht, H. D., Weigel, R., Buchman, C. G., and Hill, S. A. (1986) Therapeutic Efficacy of Multiagent Chemotherapy with Drug Delivery Enhancement by Blood-Brain Barrier Modification in Glioblastoma. Neurosurgery 19, 573-582.
33. Neuwelt, E. A., Barnett, P. A., Hellström, I., Hellström, K. E., Beaumier, P., McCormick, C. I., and Weigel, R. M. (1988) Delivery of Melanoma-associated Immunoglobulin Monoclonal Antibody and Fab Fragments to Normal Brain Utilizing Osmotic Blood-Brain Barrier Disruption. Cancer Res. 48, 4725-4729.
34. Neuwelt, E. A., Barnett, P. A., Hellström, K. E., Hellström, I., McCormick, C. I., and Ramsey, F. L. (1994) Effect of Blood-Brain Barrier Disruption on Intact and Fragmented Monoclonal Antibody Localization in Intracerebral Human Lung Carcinoma Xenografts. J. Nucl. Med. 35, 1831-1841.
35. 111In Labeled Human Epidermal Growth Factor Derivatized with a Bifunctional Metal-Chelating Peptide. Bioconjugate Chem. 6, 683-690.
36. 99mTc (Review). Nucl. Med. Biol. 18, 667-676.
37. 99mTc Labeling of Peptides: Factors that Alter Radiochemical Yields and in vivo Stability. Technetium and Rhenium in Chemistry and Nuclear Medicine 4 (M. Nicolini, G. Bandolini, and U. Mazzi, Eds.) pp 319-325, SG Editoriali, Padova, Italy.
38. Riva, P., Arista, A., Tison, V., Sturiale, C., Franceschi, G., Spinelli, A., Riva, N., Casi, M., Moscatelli, G., and Frattarelli, M. (1994) Intralesional Radioimmunotherapy of Malignant Gliomas. An Effective Treatment in Recurrent Tumors. Cancer 73 (Suppl. 3), 1076-1082.
39. San-Galli, F., Vrignaud, P., Riert, J., Coindre, J. M., and Cohadon, F. (1989) Assessment of the Experimental Model of Transplanted Glioblastoma in Wistar Rats. J. Neuro-Oncol. 7, 299-304.
40. Sato, G. H., and Sato, J. D. (1989) Growth Factor Receptor Monoclonal Antibodies and Cancer Immunotherapy. J. Int. Cancer Inst. 81, 1600-1601.
41. 125I-labeled Polypeptide, Epidermal Growth Factor. Nucl. Med. Biol. 18, 241-246.
42. Snelling, L., Miyamoto, C. T., Bender, H., Brady, L. W., Steplewski, Z., Class, R., Emrich, J., and Rackover, M. A. (1995) Epidermal Growth Factor Receptor 425 Monoclonal Antibodies Radiolabeled with Iodine-125 in the Adjuvant Treatment of High-Grade Astrocytomas. Hybridoma 14, 111-114.
43. Todderud, G., and Carpenter, G. (1989) Epidermal Growth Factor: the Receptors and Its Function. BioFactors 2, 11-15.
44. Torp, S. H., Helseth, E., Dalen, A., and Unsgaard, G. (1991) Epidermal Growth Factor Receptor Expression in Human Gliomas. Cancer Immunol. Immunother. 33, 61-64.
45. Tuzi, N. L., Venter, D. J., Kumar, S., Staddon, S. L., Lemoine, N. R., and Gullick, W. J. (1991) Expression of Growth Factor Receptors in Human Brain Tumors. Br. J. Cancer 63, 227-233
46. Wilbur, D. S. (1992) Radiohalogenation of Proteins: An Overview of Radionuclides, Labeling Methods, and Reagents for Conjugate Labeling. Bioconjugate Chem. 3, 333-370.
47. Yang, W., Barth, R. F., Carpenter, D. E., and Goodman, J. H. (1996) Enhanced Delivery of Boronophenylalanine to Brain Tumors for Neutron Capture Therapy by Means of Carotid Injection and Blood-Brain Barrier Disruption. Neurosurgery 38, 985-992.
48. Yang, W., Barth, R. F., Rotaru, J. H., Moenschberger, M. L., Carpenter D. E., Joel, D. D., Nawrocki, M. M., and Goodman, J. (1997a) Enhanced Survival of Glioma Bearing Rats Following Boron Neutron Capture Therapy with Blood Brain Barrier Disruption and Intracarotid Injection of Boronphenylalanine. J. Neuro-Oncol. 33, 59-70.
49. Yang, W., Barth, R. F., Rotaru, J. H., Moenschberger, M. L., Joel, D. D., Nawrocki, M. M., Goodman, J., and Soloway A. F. (1997b) Boron Neutron Capture Therapy of Brain Tumors: Enhanced Survival Following Intracarotid Injection of Sodium Borocaptate with or without Blood-Brain Barrier Disruption. Int. J. Radiat. Oncol. Biol. Phys. 37, 663-672.
50. 186Re Labeled Antibodies be Predicted in vitro by Challenge with Cysteine? J. Nucl. Med. 34, 246P.
51. 188Re-RC-160, a Directly-Radiolabeled Somastatin Analogue. Int. J. Cancer. 65, 214-220.